RESUMEN
Bronchial asthma is a heterogeneous disease characterized by chronic airway inflammation and airway hyperresponsiveness. With the development of the whole-life-cycle health concept, the focus of treatment for bronchial asthma in children has gradually shifted from initial pharmacological control to an integrated management model of functional rehabilitation and pharmacological assistance. As a non-pharmacological integrated approach, pulmonary rehabilitation plays an equally important role in the management of childhood asthma as pharmacological treatment. Studies have shown that breathing techniques such as Buteyko breathing, pursed lip breathing, diaphragmatic breathing training, threshold-pressure inspiratory muscle training and yoga breathing can improve lung function indicators such as FEV1, FVC, PEF and MVV in children. The comprehensive pre-exercise assessment, the development of exercise prescriptions, and the implementation and evaluation of exercise effects can improve the physical fitness, neuromuscular coordination and self-confidence of children with asthma. The comprehensive interventions of health education, psychological support and nutritional intervention can improve the compliance and effectiveness of rehabilitation training. This article reviews the research progress on respiratory training, physical exercise and comprehensive interventions in the pulmonary rehabilitation of asthmatic children, to provide theoretical basis and practical guidance for the scientific and rational management of pulmonary rehabilitation of asthmatic children in clinical settings.
RESUMEN
Bronchial asthma is a heterogeneous disease characterized by chronic airway inflammation and airway hyperresponsiveness. With the development of the whole-life-cycle health concept, the focus of treatment for bronchial asthma in children has gradually shifted from pharmacological control to an integrated management model of functional rehabilitation and pharmacological assistance. As a non-pharmacological integrated approach, pulmonary rehabilitation plays an equally important role in the management of childhood asthma as pharmacological treatments. Breathing techniques such as Buteyko breathing, pursed lip breathing, diaphragmatic breathing training, threshold-pressure inspiratory muscle training and yoga breathing can improve lung function indicators such as forced expiratory volume in first second (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF) and maximal voluntary ventilation (MVV) in children. Comprehensive pre-exercise assessment, development of exercise prescriptions, and implementation and evaluation of exercise effects can improve physical fitness, neuromuscular coordination, and self-confidence of children with asthma. The comprehensive interventions of health education, psychological support and nutritional intervention can improve the compliance and effectiveness of rehabilitation training. This article reviews the research progress on respiratory training, physical exercise, and comprehensive interventions in the pulmonary rehabilitation of asthmatic children, to provide theoretical basis and practical guidance for the scientific and rational management of pulmonary rehabilitation of asthmatic children in clinical settings.
Asunto(s)
Niño , Humanos , Asma/terapia , Medicina , Ejercicio Físico , InflamaciónRESUMEN
Objective To observe the curative efficacy of adjuvant therapy of Yupingfeng particles in bronchial asthma children with recurrent respiratory tract infection (RRTI) and its influence on humoral immunity function. Methods 98 patients of bronchial asthma children with RRTI meeting the inclusion criteria were collected as observation objects. Retrospectively analyzing their clinical materials, those patients were divided into the control group (n=42) and the observation group (n=56) according to therapeutic schemes. The control group was given conventional treatments. Besides that, the observation group was given adjuvant therapy of Yupingfeng particles. Then, curative efficacy, humoral immunity related indices and adverse reactions were compared between the two groups. Results As to curative efficacy related indices after six-month follow-up, the observation group had less times of respiratory tract infection [(2.53±0.94) vs.(4.06±1.38)times], shorter asthma wheeling time and shorter time of using antibiotics [(0.67±0.12) vs. (1.74±0.52) d, (8.29±2.15) vs. (15.37±3.42) d] with all statistical differences (all P<0.05). After treatment, in comparison with the control group, levels of humoral immunity indices of serum IgA, IgG were statistically higher in the observation group [(0.93±0.17) vs. (0.49±0.11) g/L; (7.52±0.78) vs. (6.35±0.70) g/L, both P<0.05]. During the treatment, there's no case of severe adverse reactions. And the incidences of adverse reactions in the control group and the observation group were statistically same (4.8% vs. 8.9%). Conclusion Adjuvant therapy of Yupingfeng particles has well curative efficacy in bronchial asthma children with RRTI. And it can reduce occurrence of respiratory tract infection and promote humoral immunity function with minor adverse reactions.
RESUMEN
Objective To observe the curative efficacy of adjuvant therapy of Yupingfeng particles in bronchial asthma children with recurrent respiratory tract infection (RRTI) and its influence on humoral immunity function. Methods 98 patients of bronchial asthma children with RRTI meeting the inclusion criteria were collected as observation objects. Retrospectively analyzing their clinical materials, those patients were divided into the control group (n=42) and the observation group (n=56) according to therapeutic schemes. The control group was given conventional treatments. Besides that, the observation group was given adjuvant therapy of Yupingfeng particles. Then, curative efficacy, humoral immunity related indices and adverse reactions were compared between the two groups. Results As to curative efficacy related indices after six-month follow-up, the observation group had less times of respiratory tract infection [(2.53±0.94) vs.(4.06±1.38)times], shorter asthma wheeling time and shorter time of using antibiotics [(0.67±0.12) vs. (1.74±0.52) d, (8.29±2.15) vs. (15.37±3.42) d] with all statistical differences (all P<0.05). After treatment, in comparison with the control group, levels of humoral immunity indices of serum IgA, IgG were statistically higher in the observation group [(0.93±0.17) vs. (0.49±0.11) g/L; (7.52±0.78) vs. (6.35±0.70) g/L, both P<0.05]. During the treatment, there's no case of severe adverse reactions. And the incidences of adverse reactions in the control group and the observation group were statistically same (4.8% vs. 8.9%). Conclusion Adjuvant therapy of Yupingfeng particles has well curative efficacy in bronchial asthma children with RRTI. And it can reduce occurrence of respiratory tract infection and promote humoral immunity function with minor adverse reactions.